This funding opportunity supports early-stage research into medical countermeasures against chemical, biological, radiological, and nuclear (CBRN) threats. Funded activities include development of vaccines, therapeutics, and diagnostics to address these hazards. Applicants must be employed at research organisations eligible for MRC funding.
Applicants must be employed at a research organisation eligible for MRC funding. Employment at a qualifying research institution is required to apply.
